Notice of Intent to Sole Source – Illumina ILASS Automated Pipetting System

The Medical University of South Carolina (MUSC) and Hollings Cancer Center are issuing a sole‑source procurement for Illumina’s Infinium Automated Pipetting System with the proprietary Illumina Lab Automation Software Solution (ILASS). The system integrates a customized liquid‑handling robot with software that controls assay workflow, sample tracking, instrument communication, and quality control, and is uniquely qualified to run Illumina’s Infinium genotyping and methylation assays. No alternative vendor can provide a compatible system, making Illumina the only acceptable source. This purchase aims to maintain workflow continuity, ensure manufacturer support, and reduce implementation risk for the university’s genomic research programs. • Procurement of a complete automated liquid‑handling platform (hardware + ILASS software) tailored for Illumina Infinium assays. • Sole‑source justification based on proprietary software licensing and lack of compatible alternatives. • Total contract value of $75,950, covering hardware, software integration, installation, and initial training/support. • Intended to support high‑throughput genomic research at MUSC and the Hollings Cancer Center. • Contact for inquiries is the agency’s Procurement Manager, Corliss Johnson.